These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25623255)

  • 1. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
    Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
    Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell precursor acute lymphoblastic leukemia elicits an interferon-α/β response in bone marrow-derived mesenchymal stroma.
    Smeets MWE; Steeghs EMP; Orsel J; Stalpers F; Vermeeren MMP; Veltman CHJ; Slenders L; Nierkens S; Van de Ven C; Den Boer ML
    Haematologica; 2024 Jul; 109(7):2073-2084. PubMed ID: 38426282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target.
    Taurino G; Dander E; Chiu M; Pozzi G; Maccari C; Starace R; Silvestri D; Griffini E; Bianchi MG; Carubbi C; Andreoli R; Mirandola P; Valsecchi MG; Rizzari C; D'Amico G; Bussolati O
    Br J Haematol; 2024 Jul; 205(1):175-188. PubMed ID: 38736325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage.
    Pourebrahim R; Heinz Montoya R; Alaniz Z; Ostermann L; Lin PP; Liu B; Ayoub E; Burks JK; Andreeff M
    Cell Death Dis; 2023 Jun; 14(6):371. PubMed ID: 37353528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics.
    Poveda-Garavito N; Combita AL
    Front Immunol; 2023; 14():1325255. PubMed ID: 38299154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage.
    Pourebrahim R; Montoya RH; Alaniz Z; Ostermann L; Lin PP; Liu B; Ayoub E; Burks JK; Andreeff M
    Res Sq; 2023 Mar; ():. PubMed ID: 36909480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells.
    Richartz N; Pietka W; Yadav A; Bostad M; Bhagwat S; Naderi S; Naderi EH; Stokke T; Ruud E; Blomhoff HK
    J Biol Chem; 2024 Jan; 300(1):105509. PubMed ID: 38042493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of stromal cells-mediated Notch-1 in the invasion of T-ALL cells.
    Yin C; Ye J; Zou J; Lu T; Du Y; Liu Z; Fan R; Lu F; Li P; Ma D; Ji C
    Exp Cell Res; 2015 Mar; 332(1):39-46. PubMed ID: 25637217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges.
    Lee MW; Ryu S; Kim DS; Lee JW; Sung KW; Koo HH; Yoo KH
    Leukemia; 2019 Mar; 33(3):597-611. PubMed ID: 30705410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.
    Zhang H; Liu Y; Liu J; Chen J; Wang J; Hua H; Jiang Y
    J Hematol Oncol; 2024 Jan; 17(1):5. PubMed ID: 38233872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Component Dual-Functional Autoboost Strategy by Dual Photodynamic and Cyclooxygenase-2 Inhibition for Lung Cancer and Spinal Metastasis.
    Wang B; Lu ZN; Song MX; He XW; Hu ZC; Liang HF; Lu HW; Chen Q; Liang B; Yi T; Wei P; Jiang LB; Dong J
    Adv Sci (Weinh); 2024 Mar; 11(12):e2303981. PubMed ID: 38224203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.
    Hazrati A; Malekpour K; Mirsanei Z; Khosrojerdi A; Rahmani-Kukia N; Heidari N; Abbasi A; Soudi S
    Front Immunol; 2023; 14():1280601. PubMed ID: 38022534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons.
    Afkhami H; Mahmoudvand G; Fakouri A; Shadab A; Mahjoor M; Komeili Movahhed T
    Front Cell Dev Biol; 2023; 11():1255697. PubMed ID: 37849741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential.
    Slama Y; Ah-Pine F; Khettab M; Arcambal A; Begue M; Dutheil F; Gasque P
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
    Elshazly AM; Nguyen TVV; Gewirtz DA
    Oncol Res; 2022; 30(1):1-12. PubMed ID: 37304006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time- and Concentration-Dependent Effects of the Stem Cells Derived from Human Exfoliated Deciduous Teeth on Osteosarcoma Cells.
    Alipour R; Hashemibeni B; Asgari V; Bahramian H
    Adv Biomed Res; 2023; 12():81. PubMed ID: 37200742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells.
    Kulesza A; Paczek L; Burdzinska A
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming tumor resistance mechanisms in CAR-NK cell therapy.
    Valeri A; García-Ortiz A; Castellano E; Córdoba L; Maroto-Martín E; Encinas J; Leivas A; Río P; Martínez-López J
    Front Immunol; 2022; 13():953849. PubMed ID: 35990652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stroma/stem cells: Haematologists' friend or foe?
    Nachmias B; Zimran E; Avni B
    Br J Haematol; 2022 Oct; 199(2):175-189. PubMed ID: 35667616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.